- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Strides Pharma Science Limited — Updates, 27-06-2026: Press Release
27-06-2026 | 03:57 pm
27-06-2026 | 03:57 pm
Strides Pharma partners with Ascent Capital for Pivot Path. Strides realizes 100 Cr, retaining ~20% stake. Pivot Path, now valued at 230 Cr, secures 50 Cr primary capital for growth. This bolsters Strides' balance sheet and funds Pivot Path's expansion.
No comments yet. Be the first to comment!